Purchase Order 75N93019P00987

Award Date 8/14/19
Potential Completion Date 9/16/19
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11226, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Mirimus, Inc., a self-certified small disadvantaged business. The $17,147.50 contract is for the delivery of custom vector expressions to support biomedical research. Mirimus is a provider of customized mouse models and reagents, specializing in reversible gene silencing technologies. In addition to...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Mirecule, Inc., a self-certified small disadvantaged business, to develop chemically modified mimics of microRNAs with improved activity and stability for the treatment of many diseases. The contract has a firm fixed price of $305,000.00 and a completion date of December 31, 2019. The...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
This is a $299,820.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Biological Mimetics, Inc. for a Phase I Small Business Innovation Research (SBIR) project to develop a CRISPR-based diagnostic test for parasites. The contract is not set aside. Biological Mimetics is a biotechnology firm that conducts research and development on infectious diseases, vaccines, diagnostics, and...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ingenious Targeting Laboratory Inc. The contract is valued at $31,245.00 and has a completion date of December 31, 2013. The contract is for the provision of ROSA26 knock-in mice, which are genetically modified mouse models used in biomedical research. The contract was set aside for small businesses, and Ingenious...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $786,726.00 delivery order contract to Medical Science & Computing, LLC to provide genotyping and genetic monitoring services for transgenic mice. The contract has a period of performance from April 25, 2022 through April 24, 2023 and utilizes a time and materials pricing structure. The work will be performed in Bethesda, Maryland to support the Division of Intramural Research's efforts to...
This $596,519 fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Ampersand Biosciences LLC, a woman-owned small business. The contract is for the development of reagents to support immunologic analysis of non-mammalian and underrepresented mammalian models, such as ferrets and mice, under SBIR Topic 107. This aligns with NIAID's mission to conduct and support research to...
This firm-fixed-price purchase order, valued at $24,200.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Ingenious Targeting Laboratory Inc. for the design and creation of a targeting vector. Ingenious Targeting Laboratory Inc. is a minority-owned, Asian-Pacific American owned, and self-certified small disadvantaged business that provides custom gene targeting and mouse model services. The contract did not have a...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a Delivery Order contract to Illumina, Inc., a manufacturer of genetic and genomic analysis solutions. The $18,139.37 firm fixed price award is for the provision of a mouse methylation array, with a completion date of September 17, 2024. Illumina, as a for-profit organization and manufacturer, has previously received prime federal contracts from agencies like...
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $28,590.00 firm fixed-price purchase order contract to Abveris, Inc. to provide hybridoma generation cell panel services using mice. This sole-source contract was issued under the authority of 41 U.S.C. 253 (c) (1) as implemented by FAR 13.106-1, as no other source could provide the required proprietary Abveris hyperimmune DiversimAb mice and associated services. The contract...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Mirimus, Inc., a self-certified small disadvantaged business, for $17,147.50. The contract is for the provision of custom vector expressions. Mirimus, Inc. specializes in engineering mouse models with reversible gene silencing capabilities using RNA interference and has provided scientific supplies, reagents, custom vector expressions, and mouse breeding and genotyping services to various NIH institutes. This award does not have a set-aside designation. Mirimus, Inc. has also delivered saliva pool testing services to the NIH under a separate $1.2 million contract to support coronavirus monitoring efforts, and conducts biomedical research related to colorectal cancer with funding from the National Cancer Institute.

Generated 6/1/24, 10:15 AM